APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Devic's Disease Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Devic's Disease Drug Market Outlook and Growth Opportunities 2026

Report ID 173983800426 December 2025197 pages

Choose your research edition.

Industry ResearchDevic's Disease Drug Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Devic's Disease Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Devic's Disease Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Devic's Disease Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Devic's Disease Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Devic's Disease Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Devic's Disease Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Devic's Disease Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Devic's Disease Drug market include CBOP, CSL, Fresenius, Grifols, Gyjtrs, Intas, Nang Kuang, Octapharma and Tianjin Kingyork, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Devic's Disease Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Devic's Disease Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Devic's Disease Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Devic's Disease Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Devic's Disease Drug Segment by Company

CBOP

CSL

Fresenius

Grifols

Gyjtrs

Intas

Nang Kuang

Octapharma

Tianjin Kingyork

Baxter

Pfizer

Sandoz

TEVA

Devic's Disease Drug Segment by Type

Glucocorticoids

Immunoglobulin

Other

Devic's Disease Drug Segment by Application

Hospitals

Clinics

Others

Devic's Disease Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Devic's Disease Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Devic's Disease Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Devic's Disease Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Devic's Disease Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Devic's Disease Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Devic's Disease Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Devic's Disease Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Devic's Disease Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Devic's Disease Drug industry.

Chapter 3: Detailed analysis of Devic's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Devic's Disease Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Devic's Disease Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Devic's Disease Drug Industry Trends Table 2. Devic's Disease Drug Industry Drivers Table 3. Devic's Disease Drug Industry Opportunities and Challenges Table 4. Devic's Disease Drug Industry Restraints Table 5. Global Devic's Disease Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Devic's Disease Drug Revenue Share by Company (2021-2026) Table 7. Global Devic's Disease Drug Sales Volume by Company (K Tons) & (2021-2026) Table 8. Global Devic's Disease Drug Sales Volume Share by Company (2021-2026) Table 9. Global Devic's Disease Drug Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Devic's Disease Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Devic's Disease Drug Key Company Manufacturing Base & Headquarters Table 12. Global Devic's Disease Drug Company, Product Type & Application Table 13. Global Devic's Disease Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Devic's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Glucocorticoids Table 18. Significant Companies of Immunoglobulin Table 19. Significant Companies of Other Table 20. Global Devic's Disease Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Tons) Table 21. Global Devic's Disease Drug Sales Volume by Type (2021-2026) & (K Tons) Table 22. Global Devic's Disease Drug Sales Volume by Type (2027-2032) & (K Tons) Table 23. Global Devic's Disease Drug Sales Volume Share by Type (2021-2026) Table 24. Global Devic's Disease Drug Sales Volume Share by Type (2027-2032) Table 25. Global Devic's Disease Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Devic's Disease Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Devic's Disease Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Devic's Disease Drug Sales Value Share by Type (2021-2026) Table 29. Global Devic's Disease Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Others Table 33. Global Devic's Disease Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Tons) Table 34. Global Devic's Disease Drug Sales Volume by Application (2021-2026) & (K Tons) Table 35. Global Devic's Disease Drug Sales Volume by Application (2027-2032) & (K Tons) Table 36. Global Devic's Disease Drug Sales Volume Share by Application (2021-2026) Table 37. Global Devic's Disease Drug Sales Volume Share by Application (2027-2032) Table 38. Global Devic's Disease Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Devic's Disease Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Devic's Disease Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Devic's Disease Drug Sales Value Share by Application (2021-2026) Table 42. Global Devic's Disease Drug Sales Value Share by Application (2027-2032) Table 43. Global Devic's Disease Drug Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 44. Global Devic's Disease Drug Sales by Region (2021-2026) & (K Tons) Table 45. Global Devic's Disease Drug Sales Market Share by Region (2021-2026) Table 46. Global Devic's Disease Drug Sales by Region (2027-2032) & (K Tons) Table 47. Global Devic's Disease Drug Sales Market Share by Region (2027-2032) Table 48. Global Devic's Disease Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Devic's Disease Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Devic's Disease Drug Sales Value Share by Region (2021-2026) Table 51. Global Devic's Disease Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Devic's Disease Drug Sales Value Share by Region (2027-2032) Table 53. Global Devic's Disease Drug Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Devic's Disease Drug Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. Global Devic's Disease Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Devic's Disease Drug Sales by Country (2021-2026) & (K Tons) Table 58. Global Devic's Disease Drug Sales Market Share by Country (2021-2026) Table 59. Global Devic's Disease Drug Sales by Country (2027-2032) & (K Tons) Table 60. Global Devic's Disease Drug Sales Market Share by Country (2027-2032) Table 61. Global Devic's Disease Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Devic's Disease Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Devic's Disease Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Devic's Disease Drug Sales Value Market Share by Country (2027-2032) Table 65. CBOP Company Information Table 66. CBOP Business Overview Table 67. CBOP Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. CBOP Devic's Disease Drug Product Portfolio Table 69. CBOP Recent Development Table 70. CSL Company Information Table 71. CSL Business Overview Table 72. CSL Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. CSL Devic's Disease Drug Product Portfolio Table 74. CSL Recent Development Table 75. Fresenius Company Information Table 76. Fresenius Business Overview Table 77. Fresenius Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Fresenius Devic's Disease Drug Product Portfolio Table 79. Fresenius Recent Development Table 80. Grifols Company Information Table 81. Grifols Business Overview Table 82. Grifols Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Grifols Devic's Disease Drug Product Portfolio Table 84. Grifols Recent Development Table 85. Gyjtrs Company Information Table 86. Gyjtrs Business Overview Table 87. Gyjtrs Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Gyjtrs Devic's Disease Drug Product Portfolio Table 89. Gyjtrs Recent Development Table 90. Intas Company Information Table 91. Intas Business Overview Table 92. Intas Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Intas Devic's Disease Drug Product Portfolio Table 94. Intas Recent Development Table 95. Nang Kuang Company Information Table 96. Nang Kuang Business Overview Table 97. Nang Kuang Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Nang Kuang Devic's Disease Drug Product Portfolio Table 99. Nang Kuang Recent Development Table 100. Octapharma Company Information Table 101. Octapharma Business Overview Table 102. Octapharma Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Octapharma Devic's Disease Drug Product Portfolio Table 104. Octapharma Recent Development Table 105. Tianjin Kingyork Company Information Table 106. Tianjin Kingyork Business Overview Table 107. Tianjin Kingyork Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Tianjin Kingyork Devic's Disease Drug Product Portfolio Table 109. Tianjin Kingyork Recent Development Table 110. Baxter Company Information Table 111. Baxter Business Overview Table 112. Baxter Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 113. Baxter Devic's Disease Drug Product Portfolio Table 114. Baxter Recent Development Table 115. Pfizer Company Information Table 116. Pfizer Business Overview Table 117. Pfizer Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 118. Pfizer Devic's Disease Drug Product Portfolio Table 119. Pfizer Recent Development Table 120. Sandoz Company Information Table 121. Sandoz Business Overview Table 122. Sandoz Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 123. Sandoz Devic's Disease Drug Product Portfolio Table 124. Sandoz Recent Development Table 125. TEVA Company Information Table 126. TEVA Business Overview Table 127. TEVA Devic's Disease Drug Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 128. TEVA Devic's Disease Drug Product Portfolio Table 129. TEVA Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Devic's Disease Drug Distributors List Table 133. Devic's Disease Drug Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Devic's Disease Drug Product Image Figure 2. Global Devic's Disease Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Devic's Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Devic's Disease Drug Sales (2021-2032) & (K Tons) Figure 5. Global Devic's Disease Drug Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Devic's Disease Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Glucocorticoids Image Figure 10. Immunoglobulin Image Figure 11. Other Image Figure 12. Global Devic's Disease Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 13. Global Devic's Disease Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Devic's Disease Drug Sales Volume Share by Type (2021-2032) Figure 15. Global Devic's Disease Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Devic's Disease Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Devic's Disease Drug Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Devic's Disease Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 22. Global Devic's Disease Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Devic's Disease Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Devic's Disease Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Devic's Disease Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Devic's Disease Drug Sales Value Share by Application (2021-2032) Figure 27. Global Devic's Disease Drug Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 28. Global Devic's Disease Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Devic's Disease Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Devic's Disease Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Devic's Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Devic's Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Devic's Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Devic's Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Devic's Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Devic's Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Devic's Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Devic's Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Devic's Disease Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Devic's Disease Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Devic's Disease Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Devic's Disease Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Devic's Disease Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Glucocorticoids
  • Immunoglobulin
  • Other
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • CBOP
  • CSL
  • Fresenius
  • Grifols
  • Gyjtrs
  • Intas
  • Nang Kuang
  • Octapharma
  • Tianjin Kingyork
  • Baxter
  • Pfizer
  • Sandoz
  • TEVA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Devic's Disease Drug Sales Value (2021-2032)
  4. 1.2.2 Global Devic's Disease Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Devic's Disease Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Devic's Disease Drug Market Dynamics
  1. 2.1 Devic's Disease Drug Industry Trends
  2. 2.2 Devic's Disease Drug Industry Drivers
  3. 2.3 Devic's Disease Drug Industry Opportunities and Challenges
  4. 2.4 Devic's Disease Drug Industry Restraints
3 Devic's Disease Drug Market by Company
  1. 3.1 Global Devic's Disease Drug Company Revenue Ranking in 2025
  2. 3.2 Global Devic's Disease Drug Revenue by Company (2021-2026)
  3. 3.3 Global Devic's Disease Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Devic's Disease Drug Average Price by Company (2021-2026)
  5. 3.5 Global Devic's Disease Drug Company Ranking (2024-2026)
  6. 3.6 Global Devic's Disease Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Devic's Disease Drug Company Product Type and Application
  8. 3.8 Global Devic's Disease Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Devic's Disease Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Devic's Disease Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Devic's Disease Drug Market by Type
  1. 4.1 Devic's Disease Drug Type Introduction
  2. 4.1.1 Glucocorticoids
  3. 4.1.2 Immunoglobulin
  4. 4.1.3 Other
  5. 4.2 Global Devic's Disease Drug Sales Volume by Type
  6. 4.2.1 Global Devic's Disease Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Devic's Disease Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Devic's Disease Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Devic's Disease Drug Sales Value by Type
  10. 4.3.1 Global Devic's Disease Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Devic's Disease Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global Devic's Disease Drug Sales Value Share by Type (2021-2032)
5 Devic's Disease Drug Market by Application
  1. 5.1 Devic's Disease Drug Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Devic's Disease Drug Sales Volume by Application
  6. 5.2.1 Global Devic's Disease Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Devic's Disease Drug Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Devic's Disease Drug Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Devic's Disease Drug Sales Value by Application
  10. 5.3.1 Global Devic's Disease Drug Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Devic's Disease Drug Sales Value by Application (2021-2032)
  12. 5.3.3 Global Devic's Disease Drug Sales Value Share by Application (2021-2032)
6 Devic's Disease Drug Regional Sales and Value Analysis
  1. 6.1 Global Devic's Disease Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Devic's Disease Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Devic's Disease Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Devic's Disease Drug Sales by Region (2027-2032)
  5. 6.3 Global Devic's Disease Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Devic's Disease Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Devic's Disease Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Devic's Disease Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Devic's Disease Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Devic's Disease Drug Sales Value (2021-2032)
  12. 6.6.2 North America Devic's Disease Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Devic's Disease Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Devic's Disease Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Devic's Disease Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Devic's Disease Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Devic's Disease Drug Sales Value (2021-2032)
  21. 6.9.2 South America Devic's Disease Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Devic's Disease Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Devic's Disease Drug Sales Value Share by Country, 2025 VS 2032
7 Devic's Disease Drug Country-level Sales and Value Analysis
  1. 7.1 Global Devic's Disease Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Devic's Disease Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Devic's Disease Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Devic's Disease Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Devic's Disease Drug Sales by Country (2027-2032)
  6. 7.4 Global Devic's Disease Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Devic's Disease Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Devic's Disease Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Devic's Disease Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Devic's Disease Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Devic's Disease Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CBOP
  2. 8.1.1 CBOP Company Information
  3. 8.1.2 CBOP Business Overview
  4. 8.1.3 CBOP Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CBOP Devic's Disease Drug Product Portfolio
  6. 8.1.5 CBOP Recent Developments
  7. 8.2 CSL
  8. 8.2.1 CSL Company Information
  9. 8.2.2 CSL Business Overview
  10. 8.2.3 CSL Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CSL Devic's Disease Drug Product Portfolio
  12. 8.2.5 CSL Recent Developments
  13. 8.3 Fresenius
  14. 8.3.1 Fresenius Company Information
  15. 8.3.2 Fresenius Business Overview
  16. 8.3.3 Fresenius Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Devic's Disease Drug Product Portfolio
  18. 8.3.5 Fresenius Recent Developments
  19. 8.4 Grifols
  20. 8.4.1 Grifols Company Information
  21. 8.4.2 Grifols Business Overview
  22. 8.4.3 Grifols Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Grifols Devic's Disease Drug Product Portfolio
  24. 8.4.5 Grifols Recent Developments
  25. 8.5 Gyjtrs
  26. 8.5.1 Gyjtrs Company Information
  27. 8.5.2 Gyjtrs Business Overview
  28. 8.5.3 Gyjtrs Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gyjtrs Devic's Disease Drug Product Portfolio
  30. 8.5.5 Gyjtrs Recent Developments
  31. 8.6 Intas
  32. 8.6.1 Intas Company Information
  33. 8.6.2 Intas Business Overview
  34. 8.6.3 Intas Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Intas Devic's Disease Drug Product Portfolio
  36. 8.6.5 Intas Recent Developments
  37. 8.7 Nang Kuang
  38. 8.7.1 Nang Kuang Company Information
  39. 8.7.2 Nang Kuang Business Overview
  40. 8.7.3 Nang Kuang Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nang Kuang Devic's Disease Drug Product Portfolio
  42. 8.7.5 Nang Kuang Recent Developments
  43. 8.8 Octapharma
  44. 8.8.1 Octapharma Company Information
  45. 8.8.2 Octapharma Business Overview
  46. 8.8.3 Octapharma Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Octapharma Devic's Disease Drug Product Portfolio
  48. 8.8.5 Octapharma Recent Developments
  49. 8.9 Tianjin Kingyork
  50. 8.9.1 Tianjin Kingyork Company Information
  51. 8.9.2 Tianjin Kingyork Business Overview
  52. 8.9.3 Tianjin Kingyork Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Tianjin Kingyork Devic's Disease Drug Product Portfolio
  54. 8.9.5 Tianjin Kingyork Recent Developments
  55. 8.10 Baxter
  56. 8.10.1 Baxter Company Information
  57. 8.10.2 Baxter Business Overview
  58. 8.10.3 Baxter Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Baxter Devic's Disease Drug Product Portfolio
  60. 8.10.5 Baxter Recent Developments
  61. 8.11 Pfizer
  62. 8.11.1 Pfizer Company Information
  63. 8.11.2 Pfizer Business Overview
  64. 8.11.3 Pfizer Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Pfizer Devic's Disease Drug Product Portfolio
  66. 8.11.5 Pfizer Recent Developments
  67. 8.12 Sandoz
  68. 8.12.1 Sandoz Company Information
  69. 8.12.2 Sandoz Business Overview
  70. 8.12.3 Sandoz Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sandoz Devic's Disease Drug Product Portfolio
  72. 8.12.5 Sandoz Recent Developments
  73. 8.13 TEVA
  74. 8.13.1 TEVA Company Information
  75. 8.13.2 TEVA Business Overview
  76. 8.13.3 TEVA Devic's Disease Drug Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 TEVA Devic's Disease Drug Product Portfolio
  78. 8.13.5 TEVA Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Devic's Disease Drug Value Chain Analysis
  2. 9.1.1 Devic's Disease Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Devic's Disease Drug Sales Mode & Process
  6. 9.2 Devic's Disease Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Devic's Disease Drug Distributors
  9. 9.2.3 Devic's Disease Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst